Evidence map›Paper›PMID 35869638›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2022

Ischemia preconditioning induces an adaptive response that defines a circulating metabolomic signature in ischemic stroke patients.

Joaquim Sol, Laura Colàs-Campàs, Gerard Mauri-Capdevila, Jessica Molina-Seguin, José Daniel Galo-Licona, Coral Torres-Querol, Núria Aymerich, Ángel Ois, Jaume Roquer, Silvia Tur and 9 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 1 country.

Joaquim SolExperimental Medicine Department, Lleida University-Lleida Biomedical Research Institute (UdL-IRBLleida), Lleida, Spain.
Laura Colàs-CampàsClinical Neurosciences Group, Institut de Recerca Biomèdica de Lleida, UdL, Lleida, Spain.
Gerard Mauri-CapdevilaClinical Neurosciences Group, Institut de Recerca Biomèdica de Lleida, UdL, Lleida, Spain.
Jessica Molina-SeguinClinical Neurosciences Group, Institut de Recerca Biomèdica de Lleida, UdL, Lleida, Spain.
José Daniel Galo-LiconaExperimental Medicine Department, Lleida University-Lleida Biomedical Research Institute (UdL-IRBLleida), Lleida, Spain.
Coral Torres-QuerolClinical Neurosciences Group, Institut de Recerca Biomèdica de Lleida, UdL, Lleida, Spain.
Núria AymerichComplejo Hospitalario de Navarra, Pamplona, Spain.
Ángel OisHospital del Mar, Barcelona, Spain.ORCID 0000-0002-1375-5950
Jaume RoquerHospital del Mar, Barcelona, Spain.
Silvia TurSon Espases Hospital, Palma de Mallorca, Spain.
María Del Carmen García-CarreiraCorporació Sanitària Parc Taulí, Sabadell, Spain.
Joan Martí-FàbregasHospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Antonio Cruz-CulebrasHospital Universitario Ramón y Cajal, Madrid, Spain.ORCID 0000-0002-2880-775X
Tomás SeguraComplejo Hospitalario Universitario de Albacete, Albacete, Spain.ORCID 0000-0003-3625-0987
Reinald PamplonaExperimental Medicine Department, Lleida University-Lleida Biomedical Research Institute (UdL-IRBLleida), Lleida, Spain.
Manel Portero-OtínExperimental Medicine Department, Lleida University-Lleida Biomedical Research Institute (UdL-IRBLleida), Lleida, Spain.
Gloria ArquéClinical Neurosciences Group, Institut de Recerca Biomèdica de Lleida, UdL, Lleida, Spain.
Mariona JovéExperimental Medicine Department, Lleida University-Lleida Biomedical Research Institute (UdL-IRBLleida), Lleida, Spain.
Francisco PurroyClinical Neurosciences Group, Institut de Recerca Biomèdica de Lleida, UdL, Lleida, Spain.ORCID 0000-0002-1808-5968
Instituto de Investigación Biomédica de Lleida · ESHospital Del Mar · ESHospital Universitari Arnau de Vilanova · ESComplejo Hospitalario de Navarra · ESComplejo Hospitalario Universitario de Albacete · ESCorporació Sanitària Parc Taulí · ESHospital de Sant Pau · ESHospital Universitario Ramón y Cajal · ESHospital Universitario Son Espases · ESInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transient ischemic attacks (TIAs) before an acute ischemic stroke (AIS) could induce ischemic tolerance (IT) phenomena. with an endogenous neuroprotective role (Ischemic preconditioning. IPC). A consecutive prospective cohort of patients with AIS were recruited from 8 different hospitals. Participants were classified by those with non-previous recent TIA vs. previous TIA (within seven days. TIA ≤7d). A total of 541 AIS patients were recruited. 40 (7.4%). of them had previous TIA ≤7d. In line with IPC. patients with TIA ≤7d showed: 1) a significantly less severe stroke at admission by NIHSS score. 2) a better outcome at 7-90 days follow-up and reduced infarct volumes. 3) a specific upregulated metabolomics/lipidomic profile composed of diverse lipid categories. Effectively. IPC activates an additional adaptive response on increasing circulation levels of structural and bioactive lipids to facilitate functional recovery after AIS which may support biochemical machinery for neuronal survival. Furthermore. previous TIA before AIS seems to facilitate the production of anti-inflammatory mediators that contribute to a better immune response. Thus. the IT phenomena contributes to a better adaptation of further ischemia. Our study provides first-time evidence of a metabolomics/lipidomic signature related to the development of stroke tolerance in AIS patients induced by recent TIA.

Indexed as

Ischemic Attack, TransientIschemic StrokeStrokeHumansIschemiaProspective Studiesacute ischemic strokeischemic preconditioninglipidomicsmetabolomicsTransient ischemic attack

Identifiers

PMID35869638
PMCPMC9670009
OpenAlexW4286685897

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.